Results 141 to 150 of about 3,388,278 (296)
"VisualSFM is a GUI application for 3D reconstruction using structure from motion (SFM)…
Consortium 3D SHS Team
core
Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu +13 more
wiley +1 more source
" 'Original Prusa i3 MK3S succède à l'imprimante 3D Original Prusa i3 MK2 ...
Consortium 3D SHS Team
core
Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola +11 more
wiley +1 more source
"RIEGL terrestrial laser scanners provide detailed and highly accurate 3D ...
Consortium 3D SHS Team
core
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
COSTRUZIONE DI MODELLI FOTO-REALISTICI DELL’EDIFICATO
La documentazione del patrimonio culturale si avvale ormai di tecniche tridimensionali in grado di memorizzare interi complessi sotto forma di modelli 3D dai quali è possibile ricavare successivamente proiezioni o rappresentazioni sia prospettiche che ...
Luigi Colombo
doaj
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source

